Outcome of Influenza Infection Managed With Oseltamivir in Lung Transplant Recipients

Journal of Heart and Lung Transplantation

Volumn 27, Issue 3, 2008, Pages 282-288

  Ison, Michael G ^a   Sharma, Amita ^a,d   Shepard, Jo Anne O ^b,d   Wain, John C ^b,d   Ginns, Leo C ^c,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Medical Service   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CEFEPIME; CIPROFLOXACIN; CYCLOSPORIN A; LEVOFLOXACIN; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; PREDNISONE; RAPAMYCIN; TACROLIMUS; VANCOMYCIN;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG TOLERABILITY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; IMAGING; INFLUENZA; LUNG FUNCTION TEST; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; MORBIDITY; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIVIRAL AGENTS; COHORT STUDIES; FEMALE; HUMANS; INFLUENZA, HUMAN; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; OSELTAMIVIR; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 40649086915     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.11.575     Document Type: Article

References (24)

1. Thompson W.W., Shay D.K., Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003) 179-186
2. Thompson W.W., Shay D.K., Weintraub E., et al. Influenza-associated hospitalizations in the United States. JAMA 292 (2004) 1333-1340
3. Ison M.G., and Hayden F.G. Viral infections in immunocompromised patients: what's new with respiratory viruses?. Curr Opin Infect Dis 15 (2002) 355-367
4. Billings J.L., Hertz M.I., Savik K., and Wendt C.H. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transplant 21 (2002) 559-566
5. Billings J.L., Hertz M.I., and Wendt C.H. Community respiratory virus infections following lung transplantation. Transplant Infect Dis 3 (2001) 138-148
6. Chakinala M.M., and Walter M.J. Community acquired respiratory viral infections after lung transplantation: clinical features and long-term consequences. Semin Thorac Cardiovasc Surg 16 (2004) 342-349
7. Garbino J., Gerbase M.W., Wunderli W., et al. Respiratory viruses and severe lower respiratory tract complications in hospitalized patients. Chest 125 (2004) 1033-1039
8. Khalifah A.P., Hachem R.R., Chakinala M.M., et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 170 (2004) 181-187
9. Kumar D., Erdman D., Keshavjee S., et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 5 (2005) 2031-2036
10. Vilchez R., McCurry K., Dauber J., et al. Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients. Transplantation 73 (2002) 1075-1078
11. Vilchez R.A., Dauber J., and Kusne S. Infectious etiology of bronchiolitis obliterans: the respiratory viruses connection-myth or reality?. Am J Transplant 3 (2003) 245-249
12. Vilchez R.A., McCurry K., Dauber J., et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2 (2002) 287-291
13. Vilchez R.A., Fung J., and Kusne S. The pathogenesis and management of influenza virus infection in organ transplant recipients. Transplant Infect Dis 4 (2002) 177-182
14. Garantziotis S., Howell D.N., McAdams H.P., et al. Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. Chest 119 (2001) 1277-1280
15. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 353 (2005) 1363-1373
16. Bright R.A., Shay D.K., Shu B., Cox N.J., and Klimov A.I. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295 (2006) 891-894
17. Ison M.G. Respiratory viral infections in transplant recipients. Curr Opin Organ Transplant 10 (2005) 312-319
18. Boehler A., Kesten S., Weder W., and Speich R. Bronchiolitis obliterans after lung transplantation: a review. Chest 114 (1998) 1411-1426
19. Moffatt S.D., Demers P., Robbins R.C., et al. Lung transplantation: a decade of experience. J Heart Lung Transplant 24 (2005) 145-151
20. Fritz R.S., Hayden F.G., Calfee D.P., et al. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis 180 (1999) 586-593
21. Update: Influenza activity-United States and worldwide, 2004-05 season. Morbid Mortal Wkly Rep 54 (2005) 631-634
22. Hayney M.S., Welter D.L., Francois M., Reynolds A.M., and Love R.B. Influenza vaccine antibody responses in lung transplant recipients. Progr Transplant 14 (2004) 346-351
23. Mazzone P.J., Mossad S.B., Mawhorter S.D., et al. The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J 18 (2001) 971-976
24. Mazzone P.J., Mossad S.B., Mawhorter S.D., Mehta A.C., and Mauer J.R. Cell-mediated immune response to influenza vaccination in lung transplant recipients. J Heart Lung Transplant 23 (2004) 1175-1181